StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Alterity Therapeutics's pe ratio was 69.7× on Aug 30, 2024, against 66.6× a year earlier. Over the last 5 years it ranged from 0.7× to 69.7×, with a median of 2.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Aug 30, 202469.7×+16.0
2023Dec 29, 202353.7×+52.1
2022Dec 30, 20221.6×−0.7
2021Dec 31, 20212.3×+0.3
2020Dec 31, 20201.9×+1.0
2019Dec 31, 20190.9×–

More Alterity Therapeutics figures

See a number that looks wrong?